ArticleExperimental & molecular medicine2024

VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.

Su-Hyang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.